Navigation Links
Watson Announces Limited Recall of Fentanyl Transdermal System
Date:8/8/2008

CORONA, Calif., Aug. 8 /PRNewswire/ -- Watson Pharmaceuticals, Inc., a leading specialty pharmaceutical company, announced today that one lot of 75 mcg/hr Fentanyl Transdermal System patches sold in the United States is being voluntarily recalled from wholesalers and pharmacies. The recalled patches are from Lot Number 92461850, have expiration dates of August 31, 2009 and were manufactured by Watson Laboratories, Inc. The affected lot of Fentanyl Transdermal System patches was shipped to customers between January 30, 2008 and March 19, 2008. No other strengths or lots were affected and the Company does not anticipate any product shortages as a result of this recall. The Company has notified the U.S. Food and Drug Administration (FDA) of the recall.

A small number of patches leaking fentanyl gel have been detected in this lot, potentially exposing patients or caregivers directly to fentanyl gel. Fentanyl patches that are leaking should not be used. No injuries have been reported in connection with the recalled lot. However, exposure to fentanyl gel may lead to serious adverse events, including respiratory depression and possible overdose, which may be fatal.

Anyone who has 75 mcg/hr Fentanyl Transdermal System patches should check the box or foil pouch for the lot number and expiration date to see if they have patches that are being recalled. Affected patches should not be handled directly. Anyone with 75 mcg/hr Fentanyl Transdermal System patches being recalled should call 800-668-4391, Monday through Friday, 8:00 a.m.-5:00 p.m. EDT, for instructions on how to return affected product.

Patients using fentanyl patches who have medical questions should contact their health-care providers.

Any adverse reactions experienced with the use of this product, and/or quality problems should also be reported to the FDA's MedWatch Program by phone at 1-800-FDA-1088, by Fax at 1-800-FDA-0178, by mail at MedWatch, FDA, 5600 Fishers Lane, Rockvill
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
2. Watson Wyatt Identifies Major Benefit Trends During Open Enrollment Season
3. Texas Affiliates of Susan G. Komen for the Cure, Sen. Kirk Watson, Rep. Patrick Rose, Singer Kelly Willis, Breast Cancer Survivors and Activists Rally for Passage of Proposition 15
4. Watson Files FDA Application for Generic YAZ(R)
5. Watson Names Mark Durand Chief Financial Officer
6. Watson and Novartis Settle Lawsuit Over Exelon(R) Patent Litigation
7. Barr Subsidiary Sues Watson and Sandoz for SEASONALE(R) Patent Infringement
8. Watson Confirms Patent Litigation With Barr Related to Seasonale(R)
9. Watson Receives FDA Approval for Generic DuoNeb(R)
10. Watson to Distribute Alendronate Tablets
11. Medical Cost Increases to Accelerate Worldwide Over Next Five Years, Watson Wyatt Poll Finds

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...mptoms, study finds , , WEDNESDAY, Nov....are among the potential problems faced by long-ter...with cisplatin-based chemotherapy, a new study has...n treated for unilateral testicular cancer between... conducted from 1998 to 2002. , The researchers...
(Date:11/25/2009)...Newswire/--TheAmericanAssociationforHomecareendors...hichisdesignedtosubstantiallyimprovetoolsandresour...roducedbySen.GeorgeLeMieux(R-Fla.). ,, TheLeMie...ionforHomecareoutlinedinits13-pointanti-fraudactio...ary.Thoseprovisionsincludecallingforreal-timeaudit...
(Date:11/25/2009)...lso can reverse a rare stomach disorder and should... researchers at Vanderbilt University Medical Cent...hickening of the stomach lining, severe abdominal ...welling in the feet and ankles due to protein loss...r. Previously, the only effective treatment was ga...
(Date:11/25/2009)...icked parts of speech colored perception of sounds... -- People can "hear" not only with their ears, bu...n fact, sensations on the skin designed to mimic c...pher sounds better, the Canadian scientists found....could use tactile information in this way," said B...
(Date:11/25/2009)...e premier resource for life science careers and in...rest™ Hotbed Campaign this morning. , ...25, 2009 -- BioSpace.com, the premier resource for...e third edition of the BioForest™ Hotbed Cam...n is a promotional effort highlighting biotechnolo...
Breaking Medicine News(10 mins):Health News:American Association for Homecare Endorses New U.S. Senate Bill, the 'Prevent Health Care Fraud Act of 2009' 2Health News:Vanderbilt scientists report first effective medical therapy for rare stomach disorder 2Health News:Your Skin Can Help Your Ears Listen 2Health News:Your Skin Can Help Your Ears Listen 3Health News:BioSpace Showcases Leading Life-Science Companies in the Northwest 2
...ico City- Mexico's Defense Services will be bound ... re-instate HIV-infected// soldiers who were fired...e Supreme Court enforced that the armed forces can... Senior officials in the army and navy have gone ...
... York, 'American Idol' judge Simon Cowell has no s...s singers' recent breakdowns// and stints in rehab....com quoted him as saying: 'It's very fashionable ...r themselves. I don't know what's going on in Spea...
...Woman was taken out of man; Not out of his hea...ed underfoot//; But out of his side to be equa...ar his heart to be loved” ???? - Anonymous ... reach their crescendo on the 8th, the Internatio...
...anence of anthrax spores in Smailholm and the bord...stigating a decontamination operation// at a villa...d. NHS Borders have deputed the New York-bas...the Borders, including Smailholm Village Hall. ...
...edical college counsellor set afire by his patient...h Chandra Bose Medical College hospital// in Jabal...ednesday. The counsellor, Sanjay Shrivastava...ines for treating AIDS. The patient was unde...
...thquake in Tehran,Iran, has injured at least 35 pe... were destroyed when a moderate// quake measuring... Wednesday. The epicentre of the quake, whic...and a stampede due to widespread panic caused the ...
Other Medicine News:Health News:Diminishing Differences and Empowering Eves 2Health News:Diminishing Differences and Empowering Eves 3
(Date:11/25/2009)...wire/--CempraPharmaceuticalsInc.todayannouncedthat...icer,willpresentatthePiperJaffray21stAnnualHealthC...YorkPalaceHotelinNewYorkCity.Dr.Fernandeswillprovi...icalprogramsforthetreatmentofdrug-resistantpathoge... ,, Foundedin2006,CempraPharmaceuticalsisapriv...
(Date:11/25/2009)...ESBURG,November25/PRNewswire/--,iThembaPharmaceuti...y,thattheyhavesignedacollaborativeagreementtojoint...ldclasscomputationalchemistryandleaddiscoveryexper...ovidemedicinaland,syntheticchemistrysupporttoproje...ork.iThembaPharmaceuticalsandPyxisDiscovery,alsoan...
(Date:11/24/2009)...e-Asia/--ChindexInternational,Inc.,("Chindex")(Nas...estern,healthcareproductsandservicesinthePeople,sR...tendthe21stAnnualPiperJaffray,"Unplugged"HealthCar...PalaceHotel. , Managementiscurrentlyscheduled...oldone-on-onemeetingsthroughouttheday.Awebcast,oft...
Breaking Medicine Technology:iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2Chindex International to Present at Piper Jaffray Health Care Conference 2WaferGen Announces that University of Texas Southwestern Medical Center Demonstrates Utility of New SmartChip 28TM 29 Nano Dispenser with WaferGens Sm 14810 1WaferGen Announces that University of Texas Southwestern Medical Center Demonstrates Utility of New SmartChip 28TM 29 Nano Dispenser with WaferGens Sm 14810 2WaferGen Announces that University of Texas Southwestern Medical Center Demonstrates Utility of New SmartChip 28TM 29 Nano Dispenser with WaferGens Sm 14810 3WaferGen Announces that University of Texas Southwestern Medical Center Demonstrates Utility of New SmartChip 28TM 29 Nano Dispenser with WaferGens Sm 14810 4Senesco Presents Pre Clinical Stability and Biological Activity Data on SNS 01 at the 2009 AACR NCI EORTC Molecular Targets and Cancer Therapeutics Co 6207 1Senesco Presents Pre Clinical Stability and Biological Activity Data on SNS 01 at the 2009 AACR NCI EORTC Molecular Targets and Cancer Therapeutics Co 6207 2Senesco Presents Pre Clinical Stability and Biological Activity Data on SNS 01 at the 2009 AACR NCI EORTC Molecular Targets and Cancer Therapeutics Co 6207 3Thoratec Investor Meeting to Review HeartMate II 28R 29 Destination Therapy Trial Data to Be Webcast 6202 1
...ecting Communities for Drug Safety,Collaboration" ... use of,electronic health information to support p... The non-profit eHealth,Initiative (eHI) announce...Food and Drug Administration (FDA) on the Sentinel...tor program aimed at improving the,nation,s abilit...
...22 On May 21,2008 at the World Congress of Cardio...rspectives in Atrial Fibrillation Management" chai..., St George,s University of,London, highlighted th...l,trial results, on the potential management of at...hmia., "ATHENA is truly a landmark trial, that ma...
Other Medicine Technology:eHealth Initiative's Drug Safety Collaboration to Partner With FDA on Sentinel Initiative 2eHealth Initiative's Drug Safety Collaboration to Partner With FDA on Sentinel Initiative 3eHealth Initiative's Drug Safety Collaboration to Partner With FDA on Sentinel Initiative 4eHealth Initiative's Drug Safety Collaboration to Partner With FDA on Sentinel Initiative 5ATHENA Clinical Results with Dronedarone (Multaq(R)) Highlighted at the World Cardiology Congress 2ATHENA Clinical Results with Dronedarone (Multaq(R)) Highlighted at the World Cardiology Congress 3ATHENA Clinical Results with Dronedarone (Multaq(R)) Highlighted at the World Cardiology Congress 4ATHENA Clinical Results with Dronedarone (Multaq(R)) Highlighted at the World Cardiology Congress 5ATHENA Clinical Results with Dronedarone (Multaq(R)) Highlighted at the World Cardiology Congress 6
PocketBilling©
MD Coder Web Edition 2006
ICD Finder
ZapBill Anesthesia
Medicine Products: